Skip to main content
. 2021 Jan 22;15(2):168–195. doi: 10.5009/gnl20288
Statement 11. After failure of bismuth quadruple therapy as first-line or second-line therapy (after failed standard triple or non-bismuth quadruple therapy), a levofloxacin triple therapy is suggested as a salvage therapy.
Grade of recommendation: weak
Level of evidence: very low
Experts’ opinions: completely agree (40.0%), mostly agree (30.0%), partially agree (13.3%), mostly disagree (16.7%), completely disagree (0%), not sure (0%)